PRKD2 as a novel target for targeting the diabetes–osteoporosis nexus
Abstract Diabetes mellitus (DM) and osteoporosis (OP) co-morbidity (DMOP) pose major health challenges owing to their complex pathophysiological interactions. The aim of this study was to identify and validate key genes implicated in the pathogenesis of both conditions. By employing the Mfuzz time-s...
Saved in:
Main Authors: | Rongjin Chen, Chenhui Yang, Hefang Xiao, Ao Yang, Changshun Chen, Fei Yang, Bo Peng, Bin Geng, Yayi Xia |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-89235-2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Jingui Shenqi Wan alleviates bone loss induced by primary osteoporosis by inhibiting osteoblast pyroptosis
by: Yuwangxuan Qian, et al.
Published: (2025-02-01) -
Prevent Osteoporosis: Catch the Silent Thief
by: Linda B. Bobroff
Published: (2017-05-01) -
Caution when using network partners for target identification in drug discovery
by: Dandan Tan, et al.
Published: (2025-04-01) -
The diagnostic value of the combined application of blood lipid metabolism markers and interleukin-6 in osteoporosis and osteopenia
by: Liping Fan, et al.
Published: (2025-02-01) -
Bioinformatics screening and clinical validation of CircRNA and related miRNA in male osteoporosis
by: Jiayi Li, et al.
Published: (2025-02-01)